Trimi tirzepatide review

Trimi is the cheapest flat-rate compounded tirzepatide we have been able to verify, at $125 a month on the annual plan — and, unusually for this market, it will tell you which pharmacy makes it.

That second part matters more than the first. Most programmes on this site will not name their compounding pharmacy at all. Trimi names two — VialsRx, with a Texas Board of Pharmacy licence number, and GreenwichRx — and says a certificate of analysis is available if you ask. In a category where "who actually made this vial" is the hardest question to get answered, that is a genuine difference.

What you will actually pay

The lowest advertised flat tirzepatide rate we have verified. It is an annual-plan price, so check the refund terms before prepaying.

$125 a month on the annual plan works out near $1,500 a year, the lowest figure in our table for compounded tirzepatide. Month-to-month pricing is not published as prominently, so confirm it before assuming the annual rate is available without the commitment.

How Trimi works

Flat-rate compounded GLP-1 programme on annual plans, with medical oversight through the Arora Health clinician network and publicly named 503A compounding pharmacies.

Intake is reviewed by clinicians through Arora Health, a 50-state network with a named medical director. The price is the same at every prescribed dose, so titrating from 2.5 mg to 15 mg does not change the bill. A six-month money-back promise is advertised, subject to terms worth reading before you rely on them.

The facts we verified

• Compounded tirzepatide advertised at $125/month on the annual plan.
• Compounded semaglutide advertised at $99/month on the annual plan.
• Price is the same at every prescribed dose.
• One flat charge covers medication, clinician visits, check-ins and free overnight shipping; no separate membership.
• Names its compounding pharmacies publicly: VialsRx (Texas Board of Pharmacy #35264) and GreenwichRx, with a certificate of analysis available on request.
• Medical oversight via Arora Health, a 50-state network led by Dr. Sean Arora, MD.
• Advertises a six-month money-back promise subject to terms.

Every figure above was checked on 2026-09-18. Pricing in this market moves, so treat anything older than a month as a starting point rather than a quote.

Where it is strong

• The cheapest verified flat rate for compounded tirzepatide in this comparison.
• Names its pharmacies with a licence number and offers a certificate of analysis — almost nobody else in this market does.
• Price does not move as your dose is adjusted.
• No membership fee stacked on the medication price.

Where it falls short

• The headline rates require an annual commitment.
• Compounded medication only, with no route to branded Zepbound or Wegovy.
• Newer and smaller than the large platforms, with a shorter public track record.

How it scored

Trimi scores 4.6 out of 5 on our published rubric, placing it 4 of 23 for tirzepatide. The weights are fixed before we look at any provider and are set out in full on how we rate.

Who it suits

Right for a cash payer who wants the lowest flat rate and cares about pharmacy provenance. Less right for someone who wants a large, long-established platform — Trimi is newer and smaller than Hims or Ro, with a shorter public track record.

Our verdict

On price and on pharmacy transparency this is the strongest listing we have added. The trade-off is scale and track record, and the annual commitment the headline rate depends on.

How it compares on tirzepatide

The full reasoning behind this order is in our best tirzepatide providers guide.